Summary
Dr. Ricky Singh from Weill Cornell and New York Presbyterian provides a comprehensive, evidence-based review of PRP therapy for musculoskeletal conditions. He walks through the mechanism of action, explaining how activated platelets release growth factors including PDGF, TGF-beta, VEGF, and EGF that drive angiogenesis, cell proliferation, and tissue repair. The episode covers specific evidence for tendinopathies (tennis elbow, Achilles tendon), osteoarthritis (knee and hip), muscle injuries, and ligament repair. Dr. Singh also addresses key challenges including lack of standardized preparation protocols, the significant placebo effect in studies, uncertain optimal dosing frequency, and cost/insurance barriers. He outlines ongoing research at Weill Cornell including clinical trials, mechanistic studies, and digital health integration.
Key Points
- PRP works by releasing growth factors (PDGF, TGF-beta, VEGF, EGF) that drive angiogenesis, cell proliferation, and tissue repair
- A 2017 meta-analysis concluded PRP was more effective than controls for tennis elbow pain and function
- PRP showed significant improvements over hyaluronic acid for knee osteoarthritis in multiple studies
- For osteoarthritis, PRP reduces pro-inflammatory cytokines and stimulates chondrocyte proliferation and cartilage repair
- PRP has been explored as an adjunct to ACL surgical repair and for MCL injuries
- Lack of standardized PRP preparation protocols is a major challenge contributing to variable outcomes
- PRP is expensive and rarely covered by insurance, limiting accessibility
- Future directions include personalized medicine, combination therapies, and enhanced PRP formulations
Key Moments
How PRP activates growth factors to drive tissue repair
Dr. Singh explains how activated platelets release PDGF, TGF-beta, VEGF, and EGF which facilitate angiogenesis, chemotaxis, cell proliferation, and differentiation - all essential for tissue repair and regeneration.
"when platelets are activated is that they release a variety of growth factors, including platelet-derived growth factor, known as PDGF, transforming growth factor, beta, vascular endothelial growth factor, VEGF, and epidermal growth factor, EGF."
PRP outperforms hyaluronic acid for knee osteoarthritis
Multiple studies show PRP injection significantly improved pain and function compared to hyaluronic acid, the standard gel injection for knee arthritis. Evidence extends to hip arthritis as well.
"A systematic review and medical analysis in 2013 also concluded that PRP was more effective than hyaluronic acid in reducing pain and improving function."
Challenges with PRP standardization, placebo effect, and cost
Dr. Singh outlines the main challenges: lack of standardized preparation protocols leads to variable outcomes, the placebo effect is significant in subjective pain studies, optimal dosing is unclear, and PRP is expensive without insurance coverage.
"there is a large heterogeneity of PRP preparation. There's a lack of standardized protocols for administering and preparing PRP, which can contribute to variability in clinical outcomes."
Future of PRP includes personalized medicine and combination therapies
The future of PRP spans aesthetic medicine, hair restoration, sexual health, sports medicine, and chronic pain management. Advances in personalized medicine and enhanced formulations will drive its evolution.
"the future of PRP therapy and health and wellness is promising. It has potential applications spanning aesthetic medicine, hair restoration, sexual health, sports medicine, chronic pain management, and even preventative health."
